YHB Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-41,940
Closed -$4.17M 197
2019
Q3
$4.17M Sell
41,940
-2,937
-7% -$279K 0.64% 50
2019
Q2
$4.15M Sell
44,877
-1,700
-4% -$161K 0.66% 47
2019
Q1
$4.39M Sell
46,577
-43,320
-48% -$3.79M 0.69% 47
2018
Q4
$5.76M Buy
89,897
+9,188
+11% +$678K 1.03% 34
2018
Q3
$7.22M Buy
80,709
+94
+0.1% +$8.31K 1.09% 25
2018
Q2
$6.4M Sell
80,615
-1,744
-2% -$145K 1.05% 28
2018
Q1
$7.35M Buy
82,359
+27
+0% +$2.59K 1.25% 23
2017
Q4
$8.59M Buy
82,332
+7,777
+10% +$878K 1.46% 19
2017
Q3
$10.9M Sell
74,555
-9,006
-11% -$1.23M 1.94% 10
2017
Q2
$10.9M Buy
83,561
+9,886
+13% +$1.21M 1.86% 12
2017
Q1
$9.14M Buy
73,675
+2,237
+3% +$268K 1.75% 15
2016
Q4
$8.27M Buy
71,438
+2,415
+3% +$269K 1.72% 15
2016
Q3
$7.21M Sell
69,023
-4,981
-7% -$539K 1.74% 14
2016
Q2
$7.3M Buy
74,004
+3,212
+5% +$332K 1.61% 18
2016
Q1
$7.09M Sell
70,792
-6,310
-8% -$650K 1.91% 17
2015
Q4
$9.23M Sell
77,102
-4,009
-5% -$464K 2.09% 10
2015
Q3
$8.77M Sell
81,111
-150
-0.2% -$18.6K 2.07% 11
2015
Q2
$9.4M Buy
81,261
+77
+0.1% +$8.8K 2.05% 12
2015
Q1
$9.36M Sell
81,184
-1,020
-1% -$122K 2.1% 10
2014
Q4
$9.2M Sell
82,204
-520
-0.6% -$54.8K 2.11% 11
2014
Q3
$7.84M Sell
82,724
-2,960
-3% -$267K 1.88% 11
2014
Q2
$7.36M Buy
85,684
+250
+0.3% +$19K 1.78% 13
2014
Q1
$5.96M Buy
85,434
+2,440
+3% +$193K 1.51% 16
2013
Q4
$7.01M Sell
82,994
-1,334
-2% -$106K 1.88% 11
2013
Q3
$6.5M Sell
84,328
-2,720
-3% -$191K 1.92% 10
2013
Q2
$5.09M Buy
+87,048
New +$5.24M 1.59% 15

Other funds holding CELG

YHB Investment Advisors's CELG Position: Q4 2019 in Review

YHB Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 41,940 shares — an estimated $4.17M sold.

YHB Investment Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • YHB Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • YHB Investment Advisors sold 41,940 Celgene Corp shares in Q4 2019, an estimated $4.17M.
  • YHB Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • YHB Investment Advisors's Celgene Corp position peaked at $10.9M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on YHB Investment Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.